These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12269521)

  • 1. Angiotensin receptor antagonist losartan improves endothelial function of epicardial coronary arteries in patients with essential hypertension.
    Deng YB; Yang HY; Li CL; Chang Q
    Clin Cardiol; 2002 Sep; 25(9):422-8. PubMed ID: 12269521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the angiotensin receptor antagonist losartan on the response of the left main coronary artery to cold pressor test in patients with essential hypertension as assessed by echocardiography.
    Deng YB; Wang DW; Li CL; Yang HY
    Can J Cardiol; 2002 Apr; 18(4):389-96. PubMed ID: 11992132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new noninvasive method for evaluation of coronary endothelial function in hypertensive patients based on change in diameter of the left main coronary artery induced by cold pressor test using echocardiography.
    Deng YB; Wang XF; Li CL
    Clin Cardiol; 2001 Apr; 24(4):291-6. PubMed ID: 11303696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan.
    Schiffrin EL; Park JB; Intengan HD; Touyz RM
    Circulation; 2000 Apr; 101(14):1653-9. PubMed ID: 10758046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin type 1 receptor antagonism reverses abnormal coronary vasomotion in atherosclerosis.
    Prasad A; Halcox JP; Waclawiw MA; Quyyumi AA
    J Am Coll Cardiol; 2001 Oct; 38(4):1089-95. PubMed ID: 11583887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of an angiotensin II receptor blocker on the impaired function of endothelial progenitor cells in patients with essential hypertension.
    Suzuki R; Fukuda N; Katakawa M; Tsunemi A; Tahira Y; Matsumoto T; Ueno T; Soma M
    Am J Hypertens; 2014 May; 27(5):695-701. PubMed ID: 24200748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of effect of angiotensin II receptor antagonist losartan on aortic distensibility in patients with essential hypertension by echocardiography.
    Yang H; Deng Y; Li C; Bi X; Pan M; Chang Q
    J Huazhong Univ Sci Technolog Med Sci; 2002; 22(2):164-7. PubMed ID: 12658764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of losartan titrated to Losartan/Hydrochlorothiazide and amlodipine on left ventricular mass in patients with mild-to-moderate hypertension. A double-blind randomized controlled study.
    Martina B; Dieterle T; Weinbacher M; Battegay E
    Cardiology; 1999; 92(2):110-4. PubMed ID: 10702653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension.
    Zacharieva S; Atanassova I; Natchev E; Orbetzova M; Tzingilev D
    Methods Find Exp Clin Pharmacol; 2001 Apr; 23(3):153-6. PubMed ID: 11523316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and tolerability of fimasartan, a new angiotensin receptor blocker, compared with losartan (50/100 mg): a 12-week, phase III, multicenter, prospective, randomized, double-blind, parallel-group, dose escalation clinical trial with an optional 12-week extension phase in adult Korean patients with mild-to-moderate hypertension.
    Lee SE; Kim YJ; Lee HY; Yang HM; Park CG; Kim JJ; Kim SK; Rhee MY; Oh BH;
    Clin Ther; 2012 Mar; 34(3):552-568, 568.e1-9. PubMed ID: 22381711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan].
    Cice G; Ferrara L; Tagliamonte E; Russo PE; Di Benedetto A; Iacono A
    Cardiologia; 1999 Dec; 44(12):1071-6. PubMed ID: 10687258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on the efficacy and safety of losartan in elderly patients with mild to moderate essential hypertension.
    Fernández-Vega F; Abellan J; Sanz de Castro S; Cucalón JM; Maceira B; Gómez de la Cámara A
    Int Urol Nephrol; 2001; 32(4):519-23. PubMed ID: 11989539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular changes in hypertension in response to drug treatment: Effects of angiotensin receptor blockers.
    Schiffrin EL
    Can J Cardiol; 2002 May; 18 Suppl A():15A-18A. PubMed ID: 12045789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of resistance artery stiffness by treatment with the AT(1)-receptor antagonist losartan in essential hypertension.
    Park JB; Intengan HD; Schiffrin EL
    J Renin Angiotensin Aldosterone Syst; 2000 Mar; 1(1):40-5. PubMed ID: 11967798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme genotype influences the response to the angiotensin II receptor antagonist losartan in patients with hypertension.
    Nakamura Y; Tamaki S; Uchida Y; Ohmichi N; Yamaoka O; Miyauchi N; Fukuhara T; Sayama H; Yamada T; Matsuo S; Yamada Y
    Hypertens Res; 2004 Mar; 27(3):137-40. PubMed ID: 15080371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of losartan versus hydrochlorothiazide on indices of endothelial damage/dysfunction, angiogenesis and tissue factor in essential hypertension.
    Chung NA; Beevers DG; Lip G
    Blood Press; 2004; 13(3):183-9. PubMed ID: 15223728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin-converting enzyme inhibition restores flow-dependent and cold pressor test-induced dilations in coronary arteries of hypertensive patients.
    Antony I; Lerebours G; Nitenberg A
    Circulation; 1996 Dec; 94(12):3115-22. PubMed ID: 8989118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypotensive effect of losartan, a nonpeptide angiotensin II receptor antagonist, in essential hypertension.
    Tsunoda K; Abe K; Hagino T; Omata K; Misawa S; Imai Y; Yoshinaga K
    Am J Hypertens; 1993 Jan; 6(1):28-32. PubMed ID: 8427658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
    Li JS; Sharifi AM; Schiffrin EL
    J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats.
    Fang TC; Huang WC
    Hypertension; 1998 Aug; 32(2):235-42. PubMed ID: 9719048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.